What Happened?
Vaughan, ON-based Revive-Therapeutics Appointed Michael Frank as Chief Executive Officer
About the Company
Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations.
About the Person
Michael Frank is Chief Executive Officer at Revive Therapeutics. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile